Thus, multiple proteolysis-resistant GLP-1 analogs, either short- or long-lasting, have been developed for the clinical use
2 Learn more about Medicare For more information on the costs, coverage and types of Medicare plans, check out our library of Medicare articles
Full analysis #GLP1 #EmployeeBenefits #HealthcareCosts #WorkforceHealth #Aon Farheen Dam Doug Melton Lisa Stevens Laura Rissover Liz Parr Lindsay Dower, MHA Kembre Roberts, PhD Workforce-Focused Analysis on GLP-1s: Phase Two Findings aon.com To view or add a comment, sign in Novo Nordisks FDA-approved Wegovy pill, as highlighted by Ferrin Williams, PharmD MBA, marks a major shift in obesity careintroducing an oral GLP-1 option that could expand access, improve adherence, and reshape how clinicians manage chronic weight conditions
Their study, which was published in The Lancet , found that once-daily oral semaglutide taken at 25 milligrams (mg) and 50 mg did a better job in lowering blood sugar levels and promoting weight loss than the lowest dose of 14 mg
Every new patient should get: Full evaluation of BMI, weight, and comorbidities Complete check of medications and supplements Screening for contraindications like MTC or MEN-2 in family history Review of prior weight loss attempts Clear informed consent State boards are checking if contraindication screens and informed consent happened at the same visit as the prescription